SEMAX – nootropic agent. The original synthetic peptide preparation, which is an analogue of adrenocorticotropic hormone fragment (AKTG4-10) (methionyl-glutamyl-histidyl-phenylalanyl-glycyl-prolyl-proline), completely devoid of hormonal activity.
All amino acids are L – form.
Semax affects the processes associated with the formation of memory and learning, increases selective attention in the training and analysis of information, improves mnemonic function; improves organism adaptation to hypoxia, cerebral ischemia, anesthesia and other damaging effects. In terms of mental fatigue Semax facilitates concentration, improves operator activity, contributes to the preservation and accelerates the recovery of mental performance.
Semax improves energy processes in the brain, increasing its resistance to stress damage, hypoxia.
SEMAX, indications for use
Intellectual-mental disorders in vascular brain lesions, post-traumatic brain injury and brain surgery; for the prevention and treatment of disorders postanesthesia and asthenic-neurotic disorders of various origins, including after ionizing radiation. To increase the adaptive capacities of the human body in extreme situations, prevention of mental fatigue when the monotone operator activity in the most intense periods of work in emergency conditions.
In ophthalmology Semaks used in optic nerve atrophy, neuritis, inflammatory, toxic and allergic etiology.
In pediatrics: as nootropic agents in children aged 5 to 14 years in the treatment of minimal brain dysfunction (including ADHD – Attention Deficit Hyperactivity Disorder).